Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1/2 1

Status

Completed 4Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Neoplasms 10Colorectal Cancer Metastatic 6Neoplasm Metastasis 5Lymphoma, Non-Hodgkin 5Colorectal Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Burkitt Lymphoma 4Uterine Cervical Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vulvar Neoplasms 2Vaginal Neoplasms 2Urinary Bladder Neoplasms 2Urethral Neoplasms 2Testicular Neoplasms 2Sarcoma 2Penile Neoplasms 2Lymphoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2

Interventions

aflibercept 6Oxaliplatin 3Leucovorin 3Irinotecan 3Fluorouracil 2Capecitabine 2Bevacizumab 2trifluridine tipiracil drug combination 1raltitrexed 1monoclonal antibody YYB-101 1masitinib 1atezolizumab 1Vemurafenib 1Panitumumab 1Nivolumab 1IFL protocol 1HMPL-013 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Colorectal Cancer Metastatic × aflibercept × Clear all
NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Sanofi

Phase 3 Completed
781 enrolled 28 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01882868 2017-03-14

A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

Sanofi

Phase 2 Completed
62 enrolled 34 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01670721 2016-11-28

AFEQT

Sanofi

Phase 3 Completed
175 enrolled 6 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01661270 2016-10-18

AFLAME

Sanofi

Phase 3 Completed
332 enrolled 9 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01955629 2016-04-18

AMOR

Sanofi

Phase 1/2 Terminated
4 enrolled 7 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT02085005 2014-11-18

Drop and Go

Sanofi

Phase 2 Withdrawn
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡